University Of Birmingham
Clinical trials sponsored by University Of Birmingham, explained in plain language.
-
New hope for kids with tough neuroblastoma: blood vessel blocker shows promise
Disease control CompletedThis study tested whether adding bevacizumab (a drug that cuts off a tumor's blood supply) to standard chemotherapy helps children aged 1 to 21 with neuroblastoma that has come back or not responded to treatment. About 225 children took part. The goal was to see if the combinatio…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Personalized lung cancer treatment shows promise in major trial
Disease control CompletedThis trial tested several targeted drugs in people with non-small cell lung cancer whose tumors had specific genetic markers. The goal was to see if these drugs could shrink tumors or delay cancer growth. Over 400 participants received treatment matched to their cancer's genetic …
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Could a common seizure drug slow a rare disease?
Disease control CompletedThis study tested the drug sodium valproate in 63 children and adults with Wolfram syndrome, a rare genetic disorder that causes vision loss, diabetes, and other problems. Participants were randomly assigned to receive either the drug or a placebo to see if it could slow the dise…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for Hard-to-Treat colorectal cancer? nivolumab trial shows promise
Disease control CompletedThis study tested the drug nivolumab in 35 people with a certain type of advanced colorectal cancer that had not responded to standard treatments. The goal was to see if the drug could stop the cancer from growing for at least 27 weeks. The trial focused on patients whose cancer …
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Apr 24, 2026 16:20 UTC
-
Cocoa drink may shield aging arteries from sitting too long
Symptom relief CompletedThis study looked at whether a cocoa drink rich in flavanols can protect blood vessel function and blood pressure in healthy older adults who sit for long periods. Twenty participants aged 65 and older drank either a high-flavanol or low-flavanol cocoa before sitting for 2 hours.…
Phase: NA • Sponsor: University of Birmingham • Aim: Symptom relief
Last updated May 06, 2026 16:11 UTC